Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,301 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,355 | 13 | $0 (2024) |
| Axsome Therapeutics, Inc. | $828.77 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $583.86 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $499.99 | 4 | $0 (2024) |
| BioXcel Therapeutics, Inc. | $475.99 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $281.81 | 2 | $0 (2024) |
| AbbVie Inc. | $150.00 | 1 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $125.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,988 | 16 | Axsome Therapeutics, Inc. ($529.71) |
| 2023 | $1,194 | 10 | Axsome Therapeutics, Inc. ($299.06) |
| 2022 | $349.23 | 4 | Alkermes, Inc. ($349.23) |
| 2019 | $124.42 | 1 | Alkermes, Inc. ($124.42) |
| 2018 | $303.64 | 3 | Alkermes, Inc. ($303.64) |
| 2017 | $341.21 | 3 | Janssen Pharmaceuticals, Inc ($240.87) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $117.48 | General |
| Category: CNS | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 06/05/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $124.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $130.22 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $129.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $92.99 | General |
| Category: Neuroscience | ||||||
| 04/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $122.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/20/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: CNS | ||||||
| 03/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $118.09 | General |
| Category: Neuropsychiatry | ||||||
| 02/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: CNS | ||||||
| 02/28/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $117.38 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $147.01 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/25/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $122.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $111.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $143.56 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $5.97 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $149.53 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/16/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 11/06/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $163.72 | General |
| Category: Neuropsychiatry | ||||||
| 10/10/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Michael Bernot, M.D
Dr. Michael Bernot, M.D is a Psychiatry healthcare provider based in Old Westbury, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225090384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bernot, M.D has received a total of $4,301 in payments from pharmaceutical and medical device companies, with $1,988 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($4,301).
Practice Information
- Specialty Psychiatry
- Location Old Westbury, NY
- Active Since 04/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1225090384
Products in Payments
- Auvelity (Drug) $828.77
- LYBALVI (Drug) $565.78
- IGALMI (Drug) $475.99
- Aristada 441 mg (Drug) $403.98
- ABILIFY MAINTENA (Drug) $375.00
- ARISTADA (Drug) $364.41
- INVEGA SUSTENNA (Drug) $342.99
- INGREZZA (Drug) $281.81
- INVEGA TRINZA (Drug) $240.87
- VRAYLAR (Drug) $150.00
- ABILIFY ASIMTUFII (Drug) $124.99
- VIVITROL (Drug) $20.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.